CBA-analyses of plasma samples, taken at 24 h post-stroke, using the mouse inflammation kit of the BD CBA, revealed significantly lower IL-6 levels in mice treated with ADA-409-052 (5.38 ± 0.354 pg/ml) when compared with vehicle-treated mice (8.27 ± 1.06 pg/ml, p = 0.027; Fig. 6g). The gene discussed is IL6; the disease is Stroke.